Hedge Fund - OrbiMed Advisors
Pmv Pharmaceuticals Inc. (PMVP)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $7,058,067 | 0.17% | 6,475,291 | $1.36 |
| 2 | 2024 - Q4 (2024-12-31) | $9,777,689 | 0.2% | 6,475,291 | $1.58 |
| 3 | 2024 - Q3 (2024-09-30) | $9,648,184 | 0.17% | 6,475,291 | $1.55 |
| 4 | 2024 - Q2 (2024-06-30) | $10,489,971 | 0.2% | 6,475,291 | $1.80 |
| 5 | 2024 - Q1 (2024-03-31) | $11,007,995 | 0.2% | 6,475,291 | $1.87 |
| 6 | 2023 - Q4 (2023-12-31) | $20,073,402 | 0.4% | 6,475,291 | $2.65 |
| 7 | 2023 - Q3 (2023-09-30) | $40,297,293 | 0.85% | 6,563,077 | $6.88 |
| 8 | 2023 - Q2 (2023-06-30) | $41,084,862 | 0.74% | 6,563,077 | $5.24 |
| 9 | 2023 - Q1 (2023-03-31) | $31,305,877 | 0.61% | 6,563,077 | $7.04 |
| 10 | 2022 - Q4 (2022-12-31) | $57,098,770 | 1.09% | 6,563,077 | $10.66 |
| 11 | 2022 - Q3 (2022-09-30) | $78,101,000 | 1.44% | 6,563,077 | $14.45 |
| 12 | 2022 - Q2 (2022-06-30) | $93,524,000 | 1.69% | 6,563,077 | $14.55 |
| 13 | 2022 - Q1 (2022-03-31) | $142,730,000 | 2.31% | 6,855,423 | $17.64 |
| 14 | 2021 - Q4 (2021-12-31) | $169,333,000 | 2.17% | 7,330,423 | $24.16 |
| 15 | 2021 - Q3 (2021-09-30) | $218,447,000 | 2.4% | 7,330,423 | $31.93 |
| 16 | 2021 - Q2 (2021-06-30) | $250,407,000 | 2.53% | 7,330,423 | $33.40 |
| 17 | 2021 - Q1 (2021-03-31) | $241,098,000 | 2.25% | 7,330,423 | $39.42 |
| 18 | 2020 - Q4 (2020-12-31) | $450,894,000 | 3.94% | 7,330,423 | $39.23 |
| 19 | 2020 - Q3 (2020-09-30) | $260,230,000 | 3.27% | 7,330,423 | $36.80 |
The displayed share prices are average quarterly stock market prices.